Scienture Holdings Changes Fiscal Year End

Ticker: SCNX · Form: 8-K · Filed: Oct 6, 2025 · CIK: 1382574

Scienture Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyScienture Holdings, Inc. (SCNX)
Form Type8-K
Filed DateOct 6, 2025
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.00001
Sentimentneutral

Sentiment: neutral

Topics: fiscal-year-change, administrative

TL;DR

Scienture Holdings (formerly TRxADE) is shifting its fiscal year end to Dec 31, effective Oct 1, 2025.

AI Summary

Scienture Holdings, Inc. filed an 8-K on October 6, 2025, reporting a change in its fiscal year end to December 31st, effective October 1, 2025. The company, formerly known as TRxADE HEALTH, INC., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.

Why It Matters

This change in fiscal year end could impact financial reporting timelines and investor expectations for when financial results will be released.

Risk Assessment

Risk Level: low — The filing is a routine administrative change regarding the company's fiscal year end, with no immediate financial or operational risks indicated.

Key Players & Entities

  • Scienture Holdings, Inc. (company) — Registrant
  • October 1, 2025 (date) — Effective date of fiscal year change
  • December 31 (date) — New fiscal year end
  • TRxADE HEALTH, INC. (company) — Former company name
  • Delaware (jurisdiction) — State of incorporation

FAQ

What is the new fiscal year end for Scienture Holdings, Inc.?

The new fiscal year end for Scienture Holdings, Inc. is December 31st.

When is the change in fiscal year end effective?

The change in fiscal year end is effective as of October 1, 2025.

What was Scienture Holdings, Inc. formerly known as?

Scienture Holdings, Inc. was formerly known as TRxADE HEALTH, INC.

In which state is Scienture Holdings, Inc. incorporated?

Scienture Holdings, Inc. is incorporated in Delaware.

What is the principal executive office address of Scienture Holdings, Inc.?

The principal executive office address is 20 Austin Blvd., Commack, NY 11725.

Filing Stats: 797 words · 3 min read · ~3 pages · Grade level 11.4 · Accepted 2025-10-06 17:25:36

Key Financial Figures

  • $0.00001 — ch registered Common Stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Dr. Narasimhan Mani Dr. Narasimhan Mani Co-Chief Executive Officer Date: October 6, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.